Abstract
Objective: To determine correlates of human papillomavirus (HPV) vaccine acceptance in mid-adult women. Methods: A convenience sample of 472 mid-adult women completed a 2-part, 69-item survey that included demographic, knowledge, and behavioral variables as potential correlates of vaccine acceptance. Univariable and multivariable logistic regression models were used to identify correlates for vaccine acceptance. Results: Mid-adult women who received the HPV vaccine were more likely to be younger than 55 years (P < .001); have had an abnormal Papanicolaou test (odds ratio [OR], 2.15; 95% CI, 1.18-3.92); understand that HPV causes cervical cancer (OR, 2.39; 95% CI, 1.08-5.30); feel at risk for HPV infection (OR, 2.14; 95% CI, 1.00-4.57), and feel it is important for their partner (OR, 25.20; 95% CI, 9.66-65.72) and children (OR, 3.54; CI, 0.51-24.56) to get the HPV vaccine. Monogamous mid-adult women (OR, 0.46; 95% CI, 0.21-1.00); women who did not want any vaccines (OR, 0.26; 95% CI, 0.07-0.92); and women who felt it was too late to get the vaccine (OR, 0.18; 95% CI, 0.08-0.44) were less likely to want the HPV vaccine. Conclusions: These clinical predictors of HPV vaccine acceptance will help clinicians recognize midadult women who may be more receptive to vaccination.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 31-37 |
| Number of pages | 7 |
| Journal | Journal of the American Board of Family Medicine |
| Volume | 21 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 1 2008 |
Fingerprint
ASJC Scopus subject areas
- Public Health, Environmental and Occupational Health
- Family Practice
Cite this
HPV vaccine acceptance among mid-adult women. / Ferris, Daron G.; Waller, Jennifer L.; Owen, Ashley; Smith, Jozette.
In: Journal of the American Board of Family Medicine, Vol. 21, No. 1, 01.01.2008, p. 31-37.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - HPV vaccine acceptance among mid-adult women
AU - Ferris, Daron G.
AU - Waller, Jennifer L.
AU - Owen, Ashley
AU - Smith, Jozette
PY - 2008/1/1
Y1 - 2008/1/1
N2 - Objective: To determine correlates of human papillomavirus (HPV) vaccine acceptance in mid-adult women. Methods: A convenience sample of 472 mid-adult women completed a 2-part, 69-item survey that included demographic, knowledge, and behavioral variables as potential correlates of vaccine acceptance. Univariable and multivariable logistic regression models were used to identify correlates for vaccine acceptance. Results: Mid-adult women who received the HPV vaccine were more likely to be younger than 55 years (P < .001); have had an abnormal Papanicolaou test (odds ratio [OR], 2.15; 95% CI, 1.18-3.92); understand that HPV causes cervical cancer (OR, 2.39; 95% CI, 1.08-5.30); feel at risk for HPV infection (OR, 2.14; 95% CI, 1.00-4.57), and feel it is important for their partner (OR, 25.20; 95% CI, 9.66-65.72) and children (OR, 3.54; CI, 0.51-24.56) to get the HPV vaccine. Monogamous mid-adult women (OR, 0.46; 95% CI, 0.21-1.00); women who did not want any vaccines (OR, 0.26; 95% CI, 0.07-0.92); and women who felt it was too late to get the vaccine (OR, 0.18; 95% CI, 0.08-0.44) were less likely to want the HPV vaccine. Conclusions: These clinical predictors of HPV vaccine acceptance will help clinicians recognize midadult women who may be more receptive to vaccination.
AB - Objective: To determine correlates of human papillomavirus (HPV) vaccine acceptance in mid-adult women. Methods: A convenience sample of 472 mid-adult women completed a 2-part, 69-item survey that included demographic, knowledge, and behavioral variables as potential correlates of vaccine acceptance. Univariable and multivariable logistic regression models were used to identify correlates for vaccine acceptance. Results: Mid-adult women who received the HPV vaccine were more likely to be younger than 55 years (P < .001); have had an abnormal Papanicolaou test (odds ratio [OR], 2.15; 95% CI, 1.18-3.92); understand that HPV causes cervical cancer (OR, 2.39; 95% CI, 1.08-5.30); feel at risk for HPV infection (OR, 2.14; 95% CI, 1.00-4.57), and feel it is important for their partner (OR, 25.20; 95% CI, 9.66-65.72) and children (OR, 3.54; CI, 0.51-24.56) to get the HPV vaccine. Monogamous mid-adult women (OR, 0.46; 95% CI, 0.21-1.00); women who did not want any vaccines (OR, 0.26; 95% CI, 0.07-0.92); and women who felt it was too late to get the vaccine (OR, 0.18; 95% CI, 0.08-0.44) were less likely to want the HPV vaccine. Conclusions: These clinical predictors of HPV vaccine acceptance will help clinicians recognize midadult women who may be more receptive to vaccination.
UR - http://www.scopus.com/inward/record.url?scp=38549141173&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=38549141173&partnerID=8YFLogxK
U2 - 10.3122/jabfm.2008.01.070103
DO - 10.3122/jabfm.2008.01.070103
M3 - Article
C2 - 18178700
AN - SCOPUS:38549141173
VL - 21
SP - 31
EP - 37
JO - Journal of the American Board of Family Medicine
JF - Journal of the American Board of Family Medicine
SN - 1557-2625
IS - 1
ER -